reports
- Jonathan Moreland
Credit Suisse Asset Management Income Fund Inc: 1 director
A director at Credit Suisse Asset Management Income Fund Inc bought 40,766 shares at 2.920USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
IFF Announces Board of Directors Changes
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable market share growth. New Board Chair: Kevin O’Byrne—an experienced IFF board member and chair of Centrica plc—will become Board Chair at the 2025 Annual Shareholder Meeting. O’Byrne will succeed Roger W. Ferguson, Jr. who has served as Chair since 2022. Ferguson notified IFF of his intent to not stand for reelection at the 2025 Annual Shareholder Meeting after 14 years of distinguished service...
IFF Names Michael DeVeau Chief Financial Officer
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced that Michael DeVeau—currently Senior Vice President, Corporate Finance and Investor Relations at IFF—has been named the company’s Executive Vice President and Chief Financial Officer, effective Jan. 1, 2025. DeVeau will succeed current CFO and Business Transformation Officer Glenn Richter, whose previously announced planned retirement will take effect at the end of 2024. “We could not be more pleased than naming Mike as our CFO,” said Erik Fyrwald, IFF CEO. “Mike is a trusted, experienced executive at IFF and has been a pivotal lead...
- MarketLine Department
Bedoukian Research Inc - Company Profile and SWOT Analysis
Summary Bedoukian Research Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Bedoukian Research Inc (Bedoukian Research) is a manufacturer of specialty aroma and flavor ingredients. The company offers a broad range of products in the areas of flavor and fragrance material...
International Flavors & Fragrances Inc: 1 director
A director at International Flavors & Fragrances Inc sold 5,000 shares at 91.755USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments Data from Eloxx’s proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in late-breaking presentation at American Society of Nephrology (ASN) Kidney Week New protein analyses confirm production of both collagen alpha 4 and collagen alpha 5 in patients post treatment with ELX-02 Results justify the need to conduct a larger clinical trial of ELX-02 in NMAS to confirm clinical benefit U.S. Food and Drug Administration (FDA) allows for continued dosing of subjects in Phase 1 trial of ZKN-013 W...
IFF Reports Third Quarter 2024 Results
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes ...
IFF Declares Dividend for Fourth Quarter 2024
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who par...
IFF to Release Third Quarter 2024 Results on November 5, 2024
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at . For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage...
IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Confe...
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Thursday, Sept. 5, 2024 at 1:30 p.m. ET. Investors may access the live webcast on the Company's website at . For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from glo...
IFF Reports Second Quarter 2024 Results
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $183 M $0.66 $588 M 20.4% $1.16 First Six Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-G...
IFF To Open New State-of-the-Art Center for Innovation in Shanghai
SHANGHAI--(BUSINESS WIRE)-- IFF (NYSE: IFF), a global leader in food and beverage, home and personal care, scent, and health—today announced that it aims to complete the renovation and expansion of its facilities in Shanghai Hongqiao Airport Business Park, Shanghai, China. The site will be fully operational by the end of August 2024. The 16,000 square-meter site, named “Shanghai Creative Center,” is IFF’s largest in Asia. The project is designed to drive the development of innovative solutions across the IFF portfolio in China and the Greater Asia market, further strengthening its global leade...
IFF Declares Dividend for Third Quarter 2024
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2024 to shareholders of record as of September 20, 2024. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who pa...
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations Positive written FDA feedback and guidance from a pre-Investigational New Drug Application (PIND) meeting provides pathway to IND application submission to initiate a Phase 2 clinical trial in the US with ELX-02 in patients with nonsense mutation alport syndrome (NMAS) Secured binding commitment for additional $3.2 million financing to...
IFF to Release Second Quarter 2024 Results on August 6, 2024
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE:IFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on Wednesday, August 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), an industry leade...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Mixed Signals, Reasons for Caution The S&P 500 uptrend remains intact, and the same can be said for the QQQ's. Despite a positive view of these two metrics, the aspect of of failed U.S. dollar breakdown coupled with the reversal. of the 10-year yields higher does give us pause. The S&P 500 breadth is showing signs of breadth divergence. 1.) The U.S. dollar has staged a false breakdown and is now on the cusp of a reversal. A decisive close through last Friday's close of 104.89 could yet negate t...
TJX TJX COMPANIES INC
SXT SENSIENT TECHNOLOGIES CORPORATION
MATX MATSON INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
ASC ARDMORE SHIPPING
SBL SAFE BULKERS INC.
GNK GENCO SHIPPING & TRADING LTD.
LCM COSTAMARE INC.
ROST ROSINTER RESTAURANTS HOLDING ORD SHS
SBLK STAR BULK CARRIERS CORP.
KEX KIRBY CORPORATION
NMM NAVIOS MARITIME PARTNERS
DAC DANAOS
HSHP HIMALAYA SHIPPING LTD.
ESEA EUROSEAS LTD
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.